Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
43.1M
-
Number of holders
-
47
-
Total 13F shares, excl. options
-
22.5M
-
Shares change
-
+22.5M
-
Total reported value, excl. options
-
$698M
-
Value change
-
+$698M
-
Number of buys
-
46
-
Price
-
$31.02
Significant Holders of Repare Therapeutics Inc. - Common Shares, no par value (RPTX) as of Q2 2020
47 filings reported holding RPTX - Repare Therapeutics Inc. - Common Shares, no par value as of Q2 2020.
Repare Therapeutics Inc. - Common Shares, no par value (RPTX) has 47 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 22.5M shares
of 43.1M outstanding shares and own 52.3% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (3.43M shares), MPM ASSET MANAGEMENT LLC (3M shares), FMR LLC (2.53M shares), CHI Advisors LLC (2.5M shares), MPM Oncology Impact Management LP (2.39M shares), Redmile Group, LLC (2.39M shares), BVF INC/IL (1.94M shares), Logos Global Management LP (667K shares), Artal Group S.A. (600K shares), and RA CAPITAL MANAGEMENT, L.P. (409K shares).
This table shows the top 47 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.